SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001485003-18-000014
Filing Date
2018-03-16
Accepted
2018-03-16 16:23:30
Documents
1
Period of Report
2018-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_152123178669006.html 4  
1 FORM 4 wf-form4_152123178669006.xml 4 4221
  Complete submission text file 0001485003-18-000014.txt   5588
Mailing Address C/O ELEVEN BIOTHERAPEUTICS 215 FIRST ST. #400 CAMBRIDGE MA 02142
Business Address
HURLY STEPHEN A (Reporting) CIK: 0001130637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 18695885

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations